Lake Street Capital Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Key Points

• Lake Street Capital has reduced its target price for Bioceres Crop Solutions (NASDAQ:BIOX) from $8.00 to $5.00, indicating a potential upside of 138.66% from the stock's previous close despite maintaining a "buy" rating.
• Other analysts have also revised their ratings, with Oppenheimer lowering their target from $7.00 to $6.00 and Canaccord Genuity dropping their target to $2.50, reflecting mixed sentiments on the stock's performance.
• As of midday trading, Bioceres shares are down to $2.10, with a market capitalization of $131.38 million and significant recent trading activity indicating shifts in investor interest.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) had its target price lowered by stock analysts at Lake Street Capital from $8.00 to $5.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Lake Street Capital's price objective would suggest a potential upside of 138.66% from the stock's previous close.

A number of other research firms have also recently weighed in on BIOX. Wall Street Zen upgraded shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a report on Sunday, August 31st. Oppenheimer lowered their price target on Bioceres Crop Solutions from $7.00 to $6.00 and set an "outperform" rating for the company in a report on Tuesday, July 15th. Brookline Capital Management lowered Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 21st. Finally, Canaccord Genuity Group reaffirmed a "hold" rating and set a $2.50 price objective (down from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of "Moderate Buy" and a consensus target price of $6.63.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX traded down $0.15 during midday trading on Wednesday, hitting $2.10. 353,932 shares of the company's stock traded hands, compared to its average volume of 235,879. Bioceres Crop Solutions has a 1 year low of $1.97 and a 1 year high of $8.93. The stock has a market capitalization of $131.38 million, a price-to-earnings ratio of -14.96, a price-to-earnings-growth ratio of 1.14 and a beta of 0.43. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.74 and a current ratio of 1.02. The firm has a fifty day moving average of $3.43 and a 200 day moving average of $4.13.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Jones Financial Companies Lllp increased its position in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after acquiring an additional 5,339 shares during the period. Bank of America Corp DE increased its position in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after acquiring an additional 3,735 shares during the period. Northern Trust Corp acquired a new stake in Bioceres Crop Solutions in the 4th quarter valued at approximately $93,000. Avanza Fonder AB acquired a new stake in Bioceres Crop Solutions in the 1st quarter valued at approximately $72,000. Finally, PDT Partners LLC acquired a new stake in Bioceres Crop Solutions in the 1st quarter valued at approximately $81,000. Hedge funds and other institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.